Skip to content

Effect of pulsatile blood flow pumps to help heart patients on renal function during surgery graft proximal coronary artery bypass grafting

Clinical trial comparing blood flow pulsating heart pumps to assist patients with non-pulsating flow of blood pumped during the patient's kidney function in the proximal graft surgery, coronary artery bypass grafting

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016102230421N1
Enrollment
72
Registered
2017-05-15
Start date
2015-04-24
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerotic heart disease. Atherosclerotic heart disease

Interventions

Intervention 1: Intervention group: With about a third of tidal volume ventilation began air volume. When the heart begins to beat with HR greater than 60 and the regular rhythm of heart through a pa
Treatment - Surgery
Intervention group: With about a third of tidal volume ventilation began air volume. When the heart begins to beat with HR greater than 60 and the regular rhythm of heart through a partial obstructio
Control group: routine care

Sponsors

Vice chancellor for research, Baqiyatallah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients referred for coronary artery bypass grafting after obtaining informed consent Exclusion criteria were included: emergency patients, obese BMI greater than 40, has a history of heart surgery, a history of liver disease and impaired liver function tests and patients with insulin-dependent diabetes, kidney disease or high creatinine are excluded.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Inotrope. Timepoint: After intervention in ICU, one and two days after intervention. Method of measurement: Clinical.;Creatinine. Timepoint: After intervention in ICU, one and two days after intervention. Method of measurement: Laboratory.

Secondary

MeasureTime frame
Blood urea nitrogen (BUN). Timepoint: After intervention in ICU, one and two days after intervention. Method of measurement: Laboratory.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzieh Lak

Baqiyatallah University of Medical Sciences

marziehlak@bmsu.ac.ir+98 21 8805 3766

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026